VRTX
Vertex Pharmaceuticals Inc
$516.68
9.29 (1.77%) Today
0.24 (0.05%) After-hours
— up— down
Market Cap
$121.09B+30.4%
Revenue (TTM)
$12.52B+10.2%
Net Income (TTM)
$4.36B+22.5%
EPS (TTM)
17.19+22.5%
Shares Out
253.81M
253.81MP/E Ratio
30.70
30.70Forward P/E
24.03
24.03Open
$528.68
$528.68Previous Close
$525.73
$525.73Day Range
$515.74 – $529.00
$515.74 – $529.0052-Week Range
$374.17 – $546.17
$374.17 – $546.17Beta
0.26
0.26Volume
846.32K
846.32KAvg Volume
1.43M
1.43MAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout VRTX
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England.
Related
News
N/AN/AN/AN/AN/A
Vertex Has Multiple Portfolio Catalysts With Favorable Risk-Reward, RBC Says
Yahoo · 1d ago
One Company’s Clinical Miss Is Another’s Moat: Vertex Rallies as Sionna’s CF Bet Collapses
Yahoo · 1d ago
5 Insightful Analyst Questions From Vertex Pharmaceuticals’s Q2 Earnings Call
Yahoo · 1d ago
Vertex (VRTX) Q2 2026 Earnings Call Transcript
Yahoo · 2d ago
Vertex Stock Jumps 5.9% as Rival Cystic Fibrosis Drug Fails
Yahoo · 3d ago